CENTER ID: | LpboA.19552.a |
ORGANISM: | Leptospira borgpetersenii serovar Hardjo-bovis (strain JB197) |
ASSOCIATED DISEASE: | |
CURRENT STATUS: | diffraction |
COMMUNITY REQUEST: | True |
NIH RISK GROUP: | 2 |
SELECT AGENT: | False |
NIH PRIORITY pathogens category: |
CENTER REFERENCE ID |
DOMAIN/REGION DESCRIPTION |
INFO | AA START |
AA STOP |
ORDER MATERIAL |
---|---|---|---|---|---|
LpboA.19552.a.B1.GE41869 | full length | 1 | 490 |
CENTER REFERENCE ID |
DOMAIN/REGION DESCRIPTION |
INFO | AA START |
AA STOP |
ORDER MATERIAL |
---|---|---|---|---|---|
LpboA.19552.a.B1.PS38489 | full length | 1 | 490 |
METHOD | RESULTS |
---|---|
comparative modelling | Robetta_2686 |
RESOURCE | REFERENCE ID |
---|---|
PATRIC ID: | fig|355276.3.peg.2766 |
UniProt: | Q04R04 |
HARVESTED ON: | 8/31/2017 |
SEQUENCED ON: | 9/29/2017 |
EXPECTED MW: | 56kDa |
OBSERVED MW: | 58kDa |
ANTIBIOTIC MARKER: | ampicillin |
COUNT OF EXPRESSION COLONIES: | Good (10-50) |
TOTAL EXPRESSION LEVEL: | Moderate Expression |
SOLUBLE EXPRESSION LEVEL | Moderate Expression |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
SEQUENCING RESULT: | |
PERCENT IDENTITY: | 100 |
PERCENT COVERAGE: | 98 |
PURIFICATION DATe: | 8/14/2018 |
CONCENTRATION: | 13.46mg/ml |
OBSERVED MW: | 56kDa |
EXPRESSION LEVEL: | Low Expression |
PROTEIN PURIFICATION BUFFER: | SEC: 20 mM HEPES pH 7.0, 300 mM NaCl, 5% glycerol, 1 mM TCEP |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
VIAL COUNT (approx.): | 2 |
VIAL VOLUME: | 110µl |
PERCENT IDENTITY: | 100 |
PERCENT COVERAGE: | 98 |